Natural products as multidrug resistance modulators in cancer
1Laboratory of Natural Products, Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Mansa Road, Bathinda, 151001, India.
Abstract:
Cancer is a prominent cause of death globally. Currently, many drugs that are in clinical practice are having a high prevalence of side effect and multidrug resistance. Risk of tumors acquiring resistance to chemotherapy (multidrug resistance) remains a significant hurdle to the successful treatment of various types of cancer. Membrane-embedded drug transporters, generally overexpressed in cancer, are the leading cause among multiple mechanisms of multidrug resistance (MDR). P-glycoprotein (P-gp) also MDR1/ABCB1, multidrug resistance associated protein 1 (MRP1/ABCC1), MRP2 and breast cancer resistance protein (BCRP/ABCG2) are considered to be a prime factor for induction of MDR. To date, several chemical substances have been tested in a number of clinical trials for their MDR modulatory activity which are not having devoid of any side effects that necessitates to find newer and safer way to tackle the current problem of multidrug resistance in cancer. The present study systematically discusses the various classes of natural products i.e flavonoids, alkaloids, terpenoids, coumarins (from plants, marine, and microorganisms) as potential MDR modulators and/or as a source of promising lead compounds. Recently a bisbenzyl isoquinoline alkaloid namely tetrandrine, isolated from Chinese herb Stephania tetrandra (Han-Fang-Chi) is in clinical trials for its MDR reversal activity.
Insights
Natural products offer a promising avenue to overcome cancer multidrug resistance (MDR). This study explores flavonoids, alkaloids, and other compounds as potential MDR modulators, seeking safer alternatives to current chemotherapy treatments.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Cancer remains a leading global cause of death, with multidrug resistance (MDR) significantly hindering effective chemotherapy.
- Overexpressed membrane drug transporters, such as P-glycoprotein (P-gp/ABCB1), MRP1/ABCC1, MRP2, and BCRP/ABCG2, are key drivers of MDR in cancer.
- Existing MDR modulators often cause side effects, highlighting the need for novel and safer therapeutic strategies.
Purpose of the Study:
- To systematically review natural products as potential modulators of cancer multidrug resistance.
- To identify promising lead compounds from various natural product classes for MDR reversal.
- To discuss the potential of natural products as safer alternatives to conventional MDR therapies.
Main Methods:
- Systematic review of scientific literature on natural products and their MDR modulatory activity.
- Categorization of natural products into classes: flavonoids, alkaloids, terpenoids, and coumarins.
- Analysis of natural products sourced from plants, marine organisms, and microorganisms.
Main Results:
- Various classes of natural products, including flavonoids and alkaloids, demonstrate significant potential as MDR modulators.
- Specific compounds like the bisbenzyl isoquinoline alkaloid tetrandrine show promising MDR reversal activity and are under clinical investigation.
- Natural products offer a diverse chemical scaffold for developing novel anticancer agents with reduced side effects.
Conclusions:
- Natural products represent a valuable resource for discovering novel MDR modulators and lead compounds in cancer therapy.
- Compounds like tetrandrine are advancing to clinical trials, indicating the therapeutic potential of natural products.
- Further research into natural products could lead to safer and more effective treatments for multidrug-resistant cancers.
Related Concept Videos
Treatment Resistant Cancers
Nature and Nurture
What is Natural Selection?
Resistivity
Resistance
The Wave Nature of Light


